Logo image
Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers
Journal article   Peer reviewed

Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers

Brian C. Tooker, Lee S. Newman, Russell P. Bowler, Antti Karjalainen, Panu Oksa, Harri Vainio, Eero Pukkala and Paul W. Brandt-Rauf
Biomarkers, v 16(2)
01 Mar 2011
PMID: 21231887

Abstract

Biotechnology & Applied Microbiology Life Sciences & Biomedicine Science & Technology Toxicology
Methods: SELDI-TOF and CART were used to identify serum biomarker profiles in 35 asbestosis patients who subsequently developed cancer and 35 did not develop cancer. Results: Three polypeptide peaks (5707.01, 6598.10, and 20,780.70 Da) could predict the development of cancer with 87% sensitivity and 70% specificity. The first two peaks were identified as KIF18A and KIF5A, respectively, and are part of the Kinesin Superfamily of proteins. Conclusions: We identified two Kinesin proteins that can be potentially used as blood biomarkers to identify asbestosis patients at risk of developing lung cancer.

Metrics

3 Record Views
20 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Biotechnology & Applied Microbiology
Toxicology
Logo image